Browsing by Subject "Immunoteràpia"
Now showing items 1-6 of 6
-
Current developments in gastric cancer: from molecular profiling to treatment strategy
(2023)Gastric cancer and gastro-oesophageal junction cancer represent a global health-care challenge. Despite the efficacy of improved chemotherapy and surgical options, these patients still have a ... -
Evolució del càncer de pulmó de cèl·lula no petita a la comarca d'Osona en els últims vint anys
(2024-10-29)La tesi analitza els canvis en el càncer de pulmó de cèl·lules no petites (CPCNP) a la comarca d’Osona (2002-2021) a partir de dades reals de 905 pacients del registre de tumors de l’Hospital Universitari ... -
Omic characterization of melanoma for the identification of potential biomarkers in response to immune checkpoint inhibitors
(Cancer bioinformatics, 2022-08)Cutaneous Malignant Melanoma (CMM) is a rapidly increasing malignancy for which immune check-point inhibition has proved efficient in inducing an anti-cancer immune response. However, not all pa-tients ... -
Optimisation of HIV-1 enveloped Virus Like Particles as a personalised vaccine platform for the delivery of cancer neoantigens
(2023-10-11)Cancer immunotherapies (CIT) stand as novel and promising strategies for the treatment of cancer. Their aim is to enhance the individual’s own immune system to recognise and eliminate cancer cells ... -
T cells specific for different latent and lytic viral proteins efficiently control epstein-barr virus-transformed B cells
(2015)Background aims. Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorders (PTLD) belong to the most dreaded complications of immunosuppression. The efficacy of EBV-specific ... -
Unveiling distinct features of long-term benefit in metastatic NSCLC patients undergoing immune checkpoint blockade
(2023-09-01)Introduction: Immunotherapy is firmly established as a treatment regimen in various solid tumors, driven by its exceptional benefits observed in a select group of patients. Despite widespread use of ...